RVL Pharmaceuticals plc Analysis
| Analyst Ratings |
|
Average Target Price
|
3.77
|
|
Average Rating
|
4.25
|
|
# Strong Buys
|
2
|
|
# Buys
|
1
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.16
|
-0.16
|
0.00
|
0.00%
|
|
2022-06-30
|
-0.21
|
-0.14
|
0.07
|
33.33%
|
|
2022-03-31
|
-0.17
|
-0.08
|
0.09
|
52.94%
|
|
2021-12-31
|
-0.27
|
-0.30
|
-0.03
|
-11.11%
|
|
2021-09-30
|
-0.31
|
-0.28
|
0.03
|
9.68%
|
|
2021-06-30
|
-0.14
|
-0.28
|
-0.14
|
-100.00%
|
|
2021-03-31
|
-0.23
|
-0.15
|
0.08
|
34.78%
|
|
2020-12-31
|
-0.24
|
-0.88
|
-0.64
|
-266.67%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.38
|
|
2021-12-31
|
-1.01
|
|
2020-12-31
|
-1.29
|
|
2019-12-31
|
-5.15
|
|
2018-12-31
|
-0.83
|